Press Release
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market
January 13, 2025
Read More at Our Investor Site
Because we make progress every day
Browse our latest press releases below, or visit our investor site directly for a complete list of all recent and archived press releases.
Press Release
Lantheus Announces Share Repurchase Program
November 20, 2024
Read More at Our Investor SitePress Release
Lantheus to Present at the Jefferies London Healthcare Conference
November 13, 2024
Read More at Our Investor SitePress Release
Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025
November 11, 2024
Read More at Our Investor SitePress Release
Lantheus Reports Third Quarter 2024 Financial Results
November 6, 2024
Read More at Our Investor SitePress Release
Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care
November 4, 2024
Read More at Our Investor SiteFor access to press releases before 2022 and full-text search capabilities, please visit our investor site.
Receive Email Alerts